USD 3.8 billion
Report ID:
SQMIG35A2997 |
Region:
Global |
Published Date: February, 2025
Pages:
198
|Tables:
59
|Figures:
73
Global Bioresorbable Polymers Market size was valued at USD 3.8 billion in 2023 and is poised to grow from USD 4.19 billion in 2024 to USD 9.18 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).
The globally increasing consumer health awareness, along with improving healthcare facilities and the rising number of surgical procedures are the primary factors aiding industry expansion.
Increasing demand for bioresorbable polymers in the healthcare industry is expected to boost the market in the coming years. As per data from the National Library of Medicine (NLM) in 2020, approximately 310 million major surgeries are conducted annually. Around 20 million surgeries are performed in Europe and 40 to 50 million in the U.S.
Orthopedic implants include suture anchors, interference screws, meniscals, and plates. These implants are mostly used as resorbable implants for shoulder surgery, anterior cruciate ligament, fracture care, and meniscal repair. These polymers are used to make implants as they remove the need for a second surgery to take out the implants and eliminate the risks associated with the second surgery thereby increasing the adoption of the market in implant surgeries.
The key drivers in the bioresorbable polymers market are the increasing demand for advanced medical devices especially in drug delivery systems, tissue engineering, and surgical implants. The widespread adoption of minimally invasive surgeries and the rise in chronic diseases are further propelling global bioresorbable polymers market growth.
Growing demand for bioresorbable polymers for drug delivery and increase in patient comfort carried by bioresorbable polymers are the major key factors driving the global market. The chemically neutral nature of bioresorbable polymers and their harmless decomposition in the body makes them perfect for drug delivery. Growing demand for bioresorbable (resorbable) polymers from the drug delivery segment is expected to be the major factor in the market’s development during the forecast period.
Market Key Attributes
In August 2024, Ashland expanded its facility in Ireland to improve the production capabilities of bioresorbable polymers, vital for upcoming demand in advanced pharmaceutical applications. Its new addition offers injectable technologies, long-acting formulations, bioresorbable devices, and tissue engineering solutions to be manufactured here.
September 2023, Zeus Inc. launched Absorv™ XSE-oriented tubing as a key addition to its bioresorbable product line. This customizable platform enhances medical device design options beyond coronary applications offering improved wall thickness uniformity and greater efficiency. The innovation aims to replace permanent metallic stents in various procedures promising better outcomes for manufacturers and patients alike. Advancements in polymer technology that enhance biodegradability and biocompatibility are contributing to the market's expansion. Regulatory support and rising healthcare expenditure are also acting as significant factors driving the bioresorbable polymers market growth.
In March 2023, Bioretec Ltd received FDA approval for its RemeOs™ trauma screw, making it the first company to introduce bioresorbable metal implants in the United States. The product eliminates the need for removal surgeries and promotes natural bone healing, thereby addressing a significant clinical need in orthopedic fracture treatment. The shift toward minimally invasive procedures is further accelerating the adoption of bioresorbable polymers. Ongoing advancements in polymer science offering improved biocompatibility and biodegradability are enhancing the performance of medical devices. Strong regulatory support and increasing investments in healthcare in the United States are driving the market's growth.
Market snapshot - 2025-2032
Global Market Size
USD 3.8 billion
Largest Segment
Orthopedics
Fastest Growth
Drug Delivery
Growth Rate
10.3% CAGR
To get more reports on the above market click here to Buy The Report
Global Bioresorbable Polymers Market is segmented by Material Type, Application and region. Based on Material Type, the market is segmented into Polylactic Acid, Polyhydroxyalkanoates, Starch Blends, Polybutylene Succinate and Polyhydroxyurethanes. Based on Application, the market is segmented into Packaging, Agriculture, Medical, Consumer Goods, Textile and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Analysis by Product
As per global bioresorbable polymers market outlook, polylactic acid (PLA) segment dominated the market and accounted for the maximum share of 30.5% of the overall revenue in 2024. PLA-based product has the advantage of getting naturally converted into lactic acid in the body at low concentrations and can be safely removed by the body’s excretory system. Also, its degradable nature allows it to safely degrade and dissolve, thus eliminating the need for secondary surgery, which requires component removal. The use of bioresorbable polymer materials, such as PLA, is expected to increase around lumbar interbody fusion. Polylactic acid exhibits stiffness, biocompatibility, and relatively high strength and high modulus, making it suitable for use in the manufacturing of fixation devices, such as arrows, washers, pins, and screws, in orthopedic surgeries.
As per global bioresorbable polymers market analysis, the polyglycolic acid segment is expected to grow at a CAGR of 14.1% during the forecast period. On account of rapid degradation as compared to other biopolymers, polyglycolic acid has witnessed growing demand in drug delivery applications. Polyglycolic acid is used for protein delivery, chemotherapeutics, vaccines, analgesics, antibiotics, siRNA, and anti-inflammatory drugs. Most often, the bioresorbable polymers are categorized into microcapsules, microspheres, nanofibers, and nanospheres to facilitate the controlled delivery of adsorbed or encapsulated payloads. The increasing demand for bioabsorbable sutures, bone fixation devices, and tissue engineering scaffolds is driving PGA adoption. As minimally invasive surgeries gain popularity, PGA-based sutures and implants are increasingly preferred due to their biocompatibility.
Analysis by Application
As per global bioresorbable polymers market forecast, orthopedics led the market with around 44.5% of bioresorbable polymers market share in 2024. Orthopedics is the leading segment in the bioresorbable polymers market due to the increasing demand for advanced materials in bone fixation devices, implants, and surgical treatments. Bioresorbable polymers like polylactic acid (PLA) and polyglycolic acid (PGA) are widely used in orthopedic applications because they gradually degrade within the body eliminating the need for removal surgeries. These materials provide excellent biocompatibility and support healing by offering mechanical strength during the recovery process. As the prevalence of musculoskeletal disorders rises and the demand for minimally invasive surgeries increases orthopedic applications of bioresorbable polymers are expanding driving market growth.
The drug delivery segment is expected to grow at the fastest CAGR of 15.7% during the forecast period. This growth can be attributed to the rising prevalence of chronic diseases and the growing aging population. In addition, drug delivery also helps in minimizing invasive procedures. Drug delivery systems, such as implantable devices or sustained-release formulations, can reduce the need for frequent invasive procedures, leading to improved patient comfort and lower healthcare costs. Companies are focusing on developing innovative and highly effective delivery systems. In June 2020, Evonik announced the launch of the RESOMER Precise platform, representing a breakthrough in custom functional polymeric excipients. This innovation empowers pharmaceutical companies to attain an unparalleled level of accuracy and precision in controlling the release profile of their parenteral drug products.
To get detailed analysis on other segments, Request For Free Sample Report
North America dominated the industry and accounted for the largest revenue share of 33.5% in 2024. This is attributed to the increasing product consumption in drug delivery and orthopedics applications in the region. The U.S. is the major hub for research & development in the healthcare industry, further driving the market growth in North America. Moreover, the rising demand for orthopedics and drug delivery applications supports the bioresorbable polymers demand in the region. According to the data provided by the American Joint Replacement Registry (AJRR) in 2022, over 2.8 million knee and hip procedures were performed across 1,250 health institutions in the U.S. This signifies a remarkable 14% increase in cumulative registered procedural volume compared to the previous year, establishing the AJRR as the world's largest arthroplasty registry in terms of volume.
Moreover, increasing healthcare expenditure in the U.S. is propelling market growth. According to the American Medical Association, in 2021, healthcare expenditure in the U.S. rose by 2.7% to reach USD 4.3 trillion, equivalent to USD 12,914 per capita. Asia Pacific is projected to grow at the fastest CAGR of 15.9% from 2023 to 2030, in terms of revenue. The growing geriatric population in countries, such as China and Japan, is driving the demand for medical procedures, which, in turn, is expected to propel the market growth. High economic growth in emerging countries and increasing consumer disposable income make APAC an attractive market for bioresorbable polymers.
The growth potential of the Asia Pacific region in the bioresorbable polymers market is huge, with several initiatives from the government and increased healthcare spending across its various countries. Programs such as India's 'Production Linked Incentive (PLI) Scheme for Medical Devices 2020' look to boost domestic manufacturing and lay down the right foundation for using bioresorbable polymers in medical applications. In addition, the development of medical device parks across the region will streamline production processes and enhance supply chains, fueling the demand for these polymers.
Brazil is the largest growing market in Latin America, driven by its expansive population, increasing healthcare investments, and growing demand for advanced medical technologies. According to the International Trade Administration, the country allocates 9.47% of its GDP in healthcare, with estimates being around approximately USD 161 billion. An enormous amount, thus spent upon health care has resulted in tremendous demand for modern medical technologies like that of bioresorbable polymers. This polymer used for different applications including drug delivery, surgical implants, and tissue engineering is also extremely popular these days because it's a highly friendly product as a better substitute
Additionally, the strong spending on healthcare across Brazil creates an attractive scenario to expand the bioresorbable polymers market. Although the trend here is not exclusively limited to Brazil, it is further gaining momentum elsewhere in Latin American countries, where the region constitutes a growing centre for this market.
The Middle East and Africa region is experiencing significant growth in healthcare, with countries like Saudi Arabia, the United Arab Emirates (UAE), and South Africa leading the way. The region's improved focus on preventive care and a strong willingness to adopt emerging medical technologies are driving advancements in healthcare solutions. Saudi Arabia, under its Vision 2030 initiative, is heavily investing in medical infrastructure and innovation.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Increasing Focus on Sustainable and Eco-Friendly Materials
Increasing Demand for Bioresorbable Polymers
Restraints
Increasing Preference for Minimally Invasive Surgeries
Stringent Regulatory Framework for Medical Devices
Request Free Customization of this report to help us to meet your business objectives.
The global bioresorbable polymers industry is highly competitive, with key players focusing on innovation, strategic partnerships, and expanding their product portfolios to maintain a strong market presence. Corbion N.V. is a global leader in sustainable solutions, specializing in lactic acid and its derivatives, which are used in medical applications such as drug delivery systems and sutures. Evonik Industries AG is another major player, offering high-performance bioresorbable polymers designed for implantable devices, tissue engineering, and controlled drug release applications.
Top Player’s Company Profiles
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to SkyQuest analysis, the market is driven by expansion in the healthcare industry, an increasing prevalence of chronic diseases, and the rising demand for specialized orthopedic and drug delivery applications. Furthermore, advanced polymer development and extensive research and development (R&D) activities represent other key factors increasing the overall bioresorbable polymers market share across the globe. The growing number of patients with orthopedic impairment is enhancing the demand for bioresorbable polymers as they are widely used in orthopedic devices. The market is driven by expansion in the healthcare industry, an increasing prevalence of chronic diseases, and the rising demand for specialized orthopedic and drug delivery applications. Furthermore, advanced polymer development and extensive research and development (R&D) activities represent other key factors increasing the overall bioresorbable polymers market share across the globe.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 3.8 billion |
Market size value in 2032 | USD 9.18 billion |
Growth Rate | 10.3% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Bioresorbable Polymers Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Bioresorbable Polymers Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Bioresorbable Polymers Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Bioresorbable Polymers Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Bioresorbable Polymers Market size was valued at USD 1110.19 Million in 2023 and is poised to grow from USD 1254.52 Million in 2024 to USD 3335.07 Million by 2032, growing at a CAGR of 13% in the forecast period (2025-2032).
The global bioresorbable polymers industry is highly competitive, with key players focusing on innovation, strategic partnerships, and expanding their product portfolios to maintain a strong market presence. Corbion N.V. is a global leader in sustainable solutions, specializing in lactic acid and its derivatives, which are used in medical applications such as drug delivery systems and sutures. Evonik Industries AG is another major player, offering high-performance bioresorbable polymers designed for implantable devices, tissue engineering, and controlled drug release applications. 'Corbion NV', 'Evonik Industries AG', 'Poly-Med Inc.', 'Foster Corp.', 'Abbott', 'Merck KGaA', 'Royal DSM NV. ', 'Ashland ', 'Sigma-Aldrich ', 'Mar-Lee Companies ', 'LACTEL Absorbable Polymers ', 'Galatea Surgical ', 'KAO Corporation', 'KLS Martin Group', '3D Biotek LLC.', 'Sunstar Suisse S.A.', 'DSM', 'Futerro'
As environmental sustainability continues to gain momentum, bioresorbable polymers are positioned as the more sustainable substitute to traditional plastics. Industries such as packaging, automotive, and agriculture are increasingly seeking sustainable materials that naturally decompose, and bioresorbable polymers offer a promising solution. Increasing plastic waste concerns and heightened regulatory pressure on environmental impact are pushing these materials into diverse non-medical applications.
Growing Demand for Medical Applications: Increasing usage of bioresorbable polymers in medicine is being noticed due to the special feature of being naturally degraded within the body and hence not requiring surgical removal. They are most valuable in applications like drug delivery systems, tissue engineering, and surgical sutures. They also have a broad range of applications in orthopedic implants, cardiovascular devices, and wound healing. As the global healthcare market expands with the aging population and its increasing demand for minimally invasive procedures, bioresorbable polymers will see increased demand.
North America dominated the industry and accounted for the largest revenue share of 33.5% in 2024. This is attributed to the increasing product consumption in drug delivery and orthopedics applications in the region. The U.S. is the major hub for research & development in the healthcare industry, further driving the market growth in North America. Moreover, the rising demand for orthopedics and drug delivery applications supports the bioresorbable polymers demand in the region. According to the data provided by the American Joint Replacement Registry (AJRR) in 2022, over 2.8 million knee and hip procedures were performed across 1,250 health institutions in the U.S. This signifies a remarkable 14% increase in cumulative registered procedural volume compared to the previous year, establishing the AJRR as the world's largest arthroplasty registry in terms of volume.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2997
[email protected]
USA +1 351-333-4748